Response to letter titled: blood pressure monitoring in patients receiving bevacizumab

By Shah S. R.   Gressett Ussery S. M.   Dowell J. E.   Liticker J.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1127-1128

Oxford University Press

Access to resources Recommend Favorite

CEA and CA19.9 as Early Predictors of Progression in Advanced/Metastatic Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy and Bevacizumab

By Petrioli Roberto   Licchetta Antonella   Roviello Giandomenico   Pascucci Alessandra   Francini Edoardo   Bargagli Gianluca   Conca Raffaele   Miano Salvatora Tindara   Marzocca Giuseppe   Francini Guido    

Cancer Investigation, Vol. 30, Iss. 1, 2012-01 ,pp. : 65-71

Informa Healthcare

Access to resources Recommend Favorite

Non-invasive monitoring of blood pressure using the Philips Intellivue MP50 monitor cannot replace invasive blood pressure techniques in surgery patients under general anesthesia

By                  

Experimental and Therapeutic Medicine, Vol. 6, Iss. 1, 2013-01 ,pp. : 9-14

Spandidos Publications

Access to resources Recommend Favorite

Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07

By                      

Oncology Reports, Vol. 28, Iss. 2, 2012-01 ,pp. : 654-658

Spandidos Publications

Access to resources Recommend Favorite

Analysis of blood pressure in elderly patients with postherpetic neuralgia

By Kume Takako   Hirose Munetaka   Yamashita Tomomitsu   Mizuno Shoji   Hosokawa Toyoshi   Sekimoto Miho   Kimura Misaka  

The Pain Clinic, Vol. 13, Iss. 2, 2001-06 ,pp. : 153-157

Maney Publishing

Access to resources Recommend Favorite